517 related articles for article (PubMed ID: 31686266)
1. Fovea-sparing internal limiting membrane peeling versus complete internal limiting membrane peeling for myopic traction maculopathy.
Iwasaki M; Miyamoto H; Okushiba U; Imaizumi H
Jpn J Ophthalmol; 2020 Jan; 64(1):13-21. PubMed ID: 31686266
[TBL] [Abstract][Full Text] [Related]
2. Fovea-Sparing versus Standard Internal Limiting Membrane Peeling for Myopic Traction Maculopathy: A Study of 102 Consecutive Cases.
Shiraki N; Wakabayashi T; Ikuno Y; Matsumura N; Sato S; Sakaguchi H; Nishida K
Ophthalmol Retina; 2020 Dec; 4(12):1170-1180. PubMed ID: 32470651
[TBL] [Abstract][Full Text] [Related]
3. Efficiency comparison with fovea-sparing internal limiting membrane peeling and complete internal limiting membrane peeling for treating myopic traction maculopathy.
Xin WJ; Jiang JZ; Ji LB; Lv WJ; Gu YX; Xiao Y
Graefes Arch Clin Exp Ophthalmol; 2022 Jan; 260(1):73-81. PubMed ID: 34309768
[TBL] [Abstract][Full Text] [Related]
4. Alterations of Foveal Architecture during Vitrectomy for Myopic Retinoschisis Identified by Intraoperative Optical Coherence Tomography.
Itoh Y; Inoue M; Kato Y; Koto T; Hirakata A
Ophthalmologica; 2019; 242(2):87-97. PubMed ID: 31203278
[TBL] [Abstract][Full Text] [Related]
5. Efficacy of non-fovea-sparing ILM peeling for symptomatic myopic foveoschisis with and without macular hole.
Al-Badawi AH; Abdelhakim MASE; Macky TA; Mortada HA
Br J Ophthalmol; 2019 Feb; 103(2):257-263. PubMed ID: 29712637
[TBL] [Abstract][Full Text] [Related]
6. Comparison between Fovea-Sparing and Complete Internal Limiting Membrane Peeling for the Treatment of Myopic Traction Maculopathy: A Systemic Review and Meta-Analysis.
Zeng Q; Yao Y; Zhao M
Ophthalmic Res; 2021; 64(6):916-927. PubMed ID: 34425571
[TBL] [Abstract][Full Text] [Related]
7. Vitrectomy with or without internal limiting membrane peeling for myopic foveoschisis.
Gui J; Ai L; Huang T
BMC Ophthalmol; 2020 Mar; 20(1):83. PubMed ID: 32131776
[TBL] [Abstract][Full Text] [Related]
8. Combined fovea-sparing internal limiting membrane peeling with internal limiting membrane flap technique for progressive myopic traction maculopathy.
Lin JP; Yang CM
Graefes Arch Clin Exp Ophthalmol; 2022 Feb; 260(2):489-496. PubMed ID: 34477928
[TBL] [Abstract][Full Text] [Related]
9. LONG-TERM OUTCOMES OF 23-GAUGE PARS PLANA VITRECTOMY WITH INTERNAL LIMITING MEMBRANE PEELING AND GAS TAMPONADE FOR MYOPIC TRACTION MACULOPATHY: A Prospective Study.
Figueroa MS; Ruiz-Moreno JM; Gonzalez del Valle F; Govetto A; de la Vega C; Plascencia RN; Contreras I; Medina JL
Retina; 2015 Sep; 35(9):1836-43. PubMed ID: 25946689
[TBL] [Abstract][Full Text] [Related]
10. Fovea-sparing internal limiting membrane peeling for myopic traction maculopathy.
Shimada N; Sugamoto Y; Ogawa M; Takase H; Ohno-Matsui K
Am J Ophthalmol; 2012 Oct; 154(4):693-701. PubMed ID: 22835515
[TBL] [Abstract][Full Text] [Related]
11. Surgical outcomes of centripetal non-fovea-sparing internal limiting membrane peeling for myopic foveoschisis with and without foveal detachment: a follow-up of at least 3 years.
Peng KL; Kung YH; Hsu CM; Chang SP; Tseng PL; Wu TT
Br J Ophthalmol; 2020 Sep; 104(9):1266-1270. PubMed ID: 31831505
[TBL] [Abstract][Full Text] [Related]
12. Vitrectomy with fovea-sparing ILM peeling versus total ILM peeling for myopic traction maculopathy: A meta-analysis.
Wu J; Xu Q; Luan J
Eur J Ophthalmol; 2021 Sep; 31(5):2596-2605. PubMed ID: 33143490
[TBL] [Abstract][Full Text] [Related]
13. FUNCTIONAL AND STRUCTURAL OUTCOMES AFTER FOVEA-SPARING INTERNAL LIMITING MEMBRANE PEELING FOR MYOPIC MACULAR RETINOSCHISIS BY MICROPERIMETRY.
Shinohara K; Shimada N; Takase H; Ohno-Matsui K
Retina; 2020 Aug; 40(8):1500-1511. PubMed ID: 31365520
[TBL] [Abstract][Full Text] [Related]
14. Fovea sparing versus complete internal limiting membrane peeling for myopic traction maculopathy: a meta-analysis.
Chen G; Mao S; Tong Y; Jiang F; Yang J; Li W
Int Ophthalmol; 2022 Mar; 42(3):765-773. PubMed ID: 34623570
[TBL] [Abstract][Full Text] [Related]
15. Vitrectomy and internal limiting membrane peeling with perfluoropropane tamponade or balanced saline solution for myopic foveoschisis.
Zheng B; Chen Y; Chen Y; Zhao Z; Zhang Z; Zheng J; You Y; Wang Q; Shen L
Retina; 2011 Apr; 31(4):692-701. PubMed ID: 21836401
[TBL] [Abstract][Full Text] [Related]
16. Vitrectomy with or without internal limiting membrane peeling for each stage of myopic traction maculopathy.
Taniuchi S; Hirakata A; Itoh Y; Hirota K; Inoue M
Retina; 2013; 33(10):2018-25. PubMed ID: 23975004
[TBL] [Abstract][Full Text] [Related]
17. VITRECTOMY WITH INTERNAL LIMITING MEMBRANE PEELING AND AIR TAMPONADE FOR MYOPIC FOVEOSCHISIS.
Rizzo S; Giansanti F; Finocchio L; Caporossi T; Barca F; Bacherini D; Cocci G; Vannucchi M; Tartaro R; Virgili G
Retina; 2019 Nov; 39(11):2125-2131. PubMed ID: 30015762
[TBL] [Abstract][Full Text] [Related]
18. Long-term outcome of internal limiting membrane peeling with and without foveal sparing in myopic foveoschisis.
Elwan MM; Abd Elghafar AE; Hagras SM; Abou Samra WA; Saleh SM
Eur J Ophthalmol; 2019 Jan; 29(1):69-74. PubMed ID: 29565695
[TBL] [Abstract][Full Text] [Related]
19. Comparison of effectiveness between complete internal limiting membrane peeling and internal limiting membrane peeling with preservation of the central fovea in combination with 25G vitrectomy for the treatment of high myopic foveoschisis.
Wang L; Wang Y; Li Y; Yan Z; Li Y; Lu L; Lu T; Wang X; Zhang S; Shang Y
Medicine (Baltimore); 2019 Mar; 98(9):e14710. PubMed ID: 30817612
[TBL] [Abstract][Full Text] [Related]
20. Efficacy of Fovea-Sparing Internal Limiting Membrane Peeling for Epiretinal Membrane Foveoschisis.
Sekine R; Kogo J; Jujo T; Sato K; Arizono I; Kawagoe T; Tokuda N; Kitaoka Y; Takagi H
Ophthalmic Res; 2022; 65(2):162-170. PubMed ID: 34788757
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
